B3-lesions of the breast: Risk of malignancy after vacuum-assisted breast biopsy versus core needle biopsy diagnosis

Affiliations

¹ Breast Surgery Unit, Department of General and Specialistic Surgery, AOU Città della Salute e della Scienza, Turin, Italy.
² Pathology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
³ Breast Screening Unit (Regional Reference Center), AOU Città della Salute e della Scienza, Turin, Italy.
⁴ Radiology Unit, Department of Medical Sciences, AOU Città della Salute e della Scienza, Turin, Italy.
⁵ Plastic Surgery Unit, Department of General and Specialistic Surgery, AOU Città della Salute e della Scienza, Turin, Italy.
⁶ Department of Medical and Surgical Sciences, Division of Statistics, AOU Città della Salute e della Scienza, Turin, Italy.

Giada Pozzi et al. Breast J. 2019 Nov.

. 2019 Nov;25(6):1308-1309.

doi: 10.1111/tbj.13476. Epub 2019 Jul 23.

¹ Breast Surgery Unit, Department of General and Specialistic Surgery, AOU Città della Salute e della Scienza, Turin, Italy.
² Pathology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
³ Breast Screening Unit (Regional Reference Center), AOU Città della Salute e della Scienza, Turin, Italy.
⁴ Radiology Unit, Department of Medical Sciences, AOU Città della Salute e della Scienza, Turin, Italy.
⁵ Plastic Surgery Unit, Department of General and Specialistic Surgery, AOU Città della Salute e della Scienza, Turin, Italy.
⁶ Department of Medical and Surgical Sciences, Division of Statistics, AOU Città della Salute e della Scienza, Turin, Italy.

No abstract available

References

1. EC Working Group on Breast Screening Pathology. Quality assurance guidelines for pathology. Perry et al. European Guidelines for Quality Assurance in Cancer Screening and Diagnosis. 2006.
1. Gruppo Italiano di Screening Mammografico (GISMA) - Gruppo Italiano di studio di Patologia Mammaria (GIPaM) Documento di consenso sulle procedure diagnostiche preoperatorie nelle lesioni mammarie. Lug.2016.
1. Rageth CJ, O’Flynn EAM, Comstock C, et al. First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat. 2016;159(2):203-213.
1. Saladin C, Haueisen H, Kampmann G, et al. Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management. Acta Radiol. 2016;57(7):815-821.
1. Mayer S, Kayser G, Rücker G, et al. Absence of epithelial atypic in B3-lesions is associated with decreased risk for malignancy. Breast. 2017;31:144-149.